A bio-compatible conduit is shown in tests with monkeys to promote regrowth of damaged nerve fibers, like those suffered in traumatic injuries. . . . → Read More: Implanted Guide Helps Regrow Damaged Body Nerves
|
|||||
|
|
Drug maker Boehringer Ingelheim is acquiring an antibody technology that blocks actions of a signaling protein associated with a range of fibrosis diseases. . . . → Read More: Pharma Gains Fibrosis Technology in $1B+ Deal  Comments are closed  Intellectual property  biomedical, biotechnology, entrepreneurs, Europe, licensing, life sciences, pharmaceuticals, preclinical, university 
A biotechnology company developing inhaled drugs for respiratory diseases agreed to provide Johnson & Johnson with access to its technology for treating lung cancer. . . . → Read More: Biotech Options Enzyme Inhibitors for Lung Cancer One comment - (Comments are closed) Intellectual property biomedical, biotechnology, cancer, licensing, life sciences, materials science, pharmaceuticals, physical sciences 
A biotechnology company developing cancer immunotherapies with synthetic viruses is licensing its technology to Takeda Pharmaceuticals. . . . → Read More: Engineered Viruses Licensed for Cancer Therapies One comment - (Comments are closed) Intellectual property, Joint ventures/collaborations biomedical, biotechnology, Canada, cancer, entrepreneurs, equity, licensing, life sciences, pharmaceuticals, university 
A university bio-engineering lab and start-up company are developing synthetic variations of viruses to more reliably deliver gene therapies. . . . → Read More: Engineered Virus Aids Gene Therapy Delivery One comment - (Comments are closed) Intellectual property, New products biomedical, biotechnology, engineering, entrepreneurs, genomics, licensing, life sciences, mathematics, pharmaceuticals, physical sciences, preclinical, university 
A biotechnology company developing treatments for skin conditions is acquiring a technology for limiting effects of genes causing asthma and allergic reactions. . . . → Read More: Biotech Licenses Gene-Limiting Technology for Allergies Comments are closed Intellectual property, Joint ventures/collaborations biomedical, biotechnology, genomics, licensing, life sciences, pharmaceuticals, university 
A company making regenerative skin therapies and a medical school research center are developing a spray-on treatment for a genetic skin disorder. . . . → Read More: Company, Univ. Lab Partner on Skin Disease Treatment Comments are closed Finance, Intellectual property, Joint ventures/collaborations Australia, biomedical, biotechnology, genomics, grant, licensing, life sciences, medical device, NIH, pharmaceuticals, preclinical, stem cells, university 
A system using an electric current to break up bacterial communities on orthopedic implants received a breakthrough-device designation from the Food and Drug Administration. . . . → Read More: FDA Tags Biofilm Disruption Device as Breakthrough Comments are closed Intellectual property, New products, Regulations biomedical, engineering, entrepreneurs, FDA, life sciences, materials science, medical device, physical sciences, physics, university 
Results from a clinical trial show an experimental treatment encourages immune-system tolerance of gluten, preventing intestinal damage from celiac disease. . . . → Read More: Trial Shows Nanotech Drug Induces Gluten Tolerance Comments are closed Intellectual property, Joint ventures/collaborations biomedical, biotechnology, clinical trials, Japan, licensing, life sciences, nanotechnology, pharmaceuticals, university 
Drug maker Merck & Co. is partnering with a developer of treatments for disease derived from microbes in the gut, for discovery of up to three vaccines. . . . → Read More: Merck Gaining Gut Microbe Technology for Vaccines Comments are closed Intellectual property, Joint ventures/collaborations biomedical, biotechnology, equity, Europe, genomics, licensing, life sciences, pharmaceuticals, preclinical, U.K. |
||||
|
Copyright © 2020 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||